Skip to content

Study of drug reactions to HIV treatment in ART centre at Allahabad, Uttar Pradesh

A study on adverse drug reactions of Antiretroviral drugs in ART Centre at a tertiary care hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/02/012138
Enrollment
150
Registered
2018-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HIV positive patients who are receiving Antiretroviral Therapy

Interventions

None listed

Sponsors

Dr Arkapal Bandyopadhyay
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All the patients registered to the ART centre who were on ART regimen were included in the study. No age restrictions is taken into account and patients from all age group were included. 2.Patients include : a) New cases- Patients who were diagnosed with HIV and were started on ART at the time of the study b) Old cases- Patients who were already taking ART before the start of the study c) Patients transferred from other ART centre and were already taking ART. 3.Patients who were willing to participate and gave consent were included in the study.

Exclusion criteria

Exclusion criteria: 1.The patients who were on observation or Pre-ART management were excluded 2.Patients who were not able to comprehend the interview questions were excluded 3.Patients with preexisting psychiatric disorders were excluded 4.Seriously ill patients who were in critical condition were excluded. The decision of seriousness of the patient was discussed with medical officer in charge of the A.R.T centre.

Design outcomes

Primary

MeasureTime frame
Adverse drug reactions to Antiretroviral TherapyTimepoint: 8 months Inclusion period-2 months Observation period- 6 months from day of inclusion

Secondary

MeasureTime frame
1. Association between variables and adverse drug reactions 2. Adherence to ART regimen and its factors Timepoint: 8 months Inclusion period-2 months Observation period- 6 months

Countries

India

Contacts

Public ContactDr Arkapal Bandyopadhyay

King George Medical University, Lucknow

drrakesh65@rediffmail.com9415615064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026